Trimada in the Management of Medoroga
Phase 2
- Conditions
- Health Condition 1: E782- Mixed hyperlipidemia
- Registration Number
- CTRI/2023/07/054809
- Lead Sponsor
- Government Ayurvedic College, Patiala
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Patients who will give written consent for the study.
2.Patients fulfiling the diagnostic criteria as per clinical performa.
3.Any one of the following:
a)Dyslipidemia in laboratory investigation.
b)Patients having raised BMI between 25-39.9kg/metre square
Exclusion Criteria
1. Persons who will not agree to give written consent for the study
2. Patients below the age of 18 years and 60 years above
3. Pregnancy and lactating mothers
4.Patients having history of severe cardiac diseases
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Subjective Parameter- Grading will be done with signs & symptoms of Dyslipidemia/Medoroga. <br/ ><br>Lipid profile, CBC, LFT, KFTTimepoint: After 45 days of intervention of Trimada Churan orally & 15 days after stopping of medicine.
- Secondary Outcome Measures
Name Time Method Subjective Parameter- Grading will be done with signs & symptoms of Dyslipidemia/Medoroga. <br/ ><br>Lipid profile, CBC, LFT, KFTTimepoint: After 45 days of intervention of Trimada Churan orally & 15 days after stopping of medicine.